[
  {
    "question_number": "Q142",
    "question_text": "",
    "options": {
      "A": "patient with progressive myoclonus and dementia is suspected to have which condition?"
    },
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q114",
    "question_text": "",
    "options": {
      "A": "63-year-old male has a 4-year history of Parkinson's Disease with visual hallucinations. What is the most likely diagnosis?"
    },
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q228",
    "question_text": "",
    "options": {
      "A": "Parkinson's patient came with increased hallucinations and memory loss; what is the treatment?"
    },
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q21",
    "question_text": "In a case scenario of a Parkinson's disease patient presenting with hallucinations and memory problems, what is the recommended treatment?",
    "options": {
      "A": "Rivastigmine",
      "B": "Quetiapine",
      "C": "Clozapine",
      "D": "Donepezil"
    },
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q109",
    "question_text": "",
    "options": {
      "A": "patient with Parkinson's disease presents with hallucinations and memory problems. What medication should be given?"
    },
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q139",
    "question_text": "Which of the following is a common side effect of cholinesterase inhibitors in individuals with parkinsonism?",
    "options": {
      "A": "Nausea",
      "B": "Worsening tremor",
      "C": "Insomnia",
      "D": "Weight gain"
    },
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q215",
    "question_text": "An 80-year-old patient presents with concerns about his memory function, as he is forgetting names of people and where he is putting his belongings; he is totally independent. What is the diagnosis?",
    "options": {
      "A": "Alzheimer disease",
      "B": "Normal aging",
      "C": "Mild cognitive impairment",
      "D": "Vascular dementia"
    },
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q74",
    "question_text": "An 80-year-old patient presents with concerns about his memory function, as he is forgetting names and where he is putting his belongings. He is totally independent. What is the likely diagnosis?",
    "options": {
      "A": "Alzheimer disease",
      "B": "Mild cognitive impairment (MCI)",
      "C": "Normal aging",
      "D": "Vascular dementia"
    },
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q207",
    "question_text": "",
    "options": {
      "A": "patient with dementia presents with insomnia and agitation. What medication would you prescribe?"
    },
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q140",
    "question_text": "What is the second most common type of neurodegenerative dementia?",
    "options": {
      "A": "Alzheimer's Disease (AD)",
      "B": "Lewy Body Dementia (LBD)",
      "C": "Frontotemporal Dementia (FTD)",
      "D": "Vascular dementia"
    },
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q184",
    "question_text": "",
    "options": {
      "A": "patient with frontotemporal dementia (FTD) shows frontal and temporal atrophy on MRI. What is the most likely diagnosis?"
    },
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q38",
    "question_text": "An elderly patient presented to the neurology clinic with complaints of progressive memory problems. The physician prescribed medication for him. After 2 weeks, he presented with nausea, anorexia, and diarrhea. Which of the following is the most likely prescribed medication?",
    "options": {
      "A": "Memantine",
      "B": "Rivastigmine",
      "C": "Donepezil",
      "D": "Galantamine"
    },
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q66",
    "question_text": "What is the mechanism of action of Donepezil?",
    "options": {
      "A": "Acetylcholine esterase inhibitor",
      "B": "Acetylcholine esterase agonist",
      "C": "NMDA antagonist",
      "D": "Dopamine receptor antagonist"
    },
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q43",
    "question_text": "",
    "options": {
      "A": "young patient with a history of memory loss has a family history of similar issues. Which gene is most likely involved?"
    },
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q225",
    "question_text": "What is the most likely diagnosis for a patient with a PET scan showing low FOG uptake in the parietal cortex and temporal and frontal regions in advanced stages?",
    "options": {
      "A": "Frontotemporal Dementia (FTD)",
      "B": "Alzheimer's Disease (AD)",
      "C": "Dementia with Lewy Bodies (DLB)",
      "D": "Parkinson's Disease (PD)"
    },
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q40",
    "question_text": "",
    "options": {
      "A": "FTLD\u2013tau type pathology",
      "B": "Alzheimer\u2019s disease pathology",
      "C": "FTLD\u2013TDP\u201343 type C pathology",
      "D": "Vascular dementia pathology"
    },
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q73",
    "question_text": "Which gene is related to early onset Alzheimer's disease (AD)?",
    "options": {
      "A": "APOE",
      "B": "APP",
      "C": "Presenilin 1",
      "D": "Presenilin 2"
    },
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q111",
    "question_text": "What is the drug that showed evidence to treat visual hallucinations in dementia with Lewy bodies (DLB)?",
    "options": {
      "A": "Rivastigmine",
      "B": "Quetiapine",
      "C": "Donepezil",
      "D": "Clonazepam"
    },
    "correct_answer": "C",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q119",
    "question_text": "In a scenario about DLB, if a patient developed hallucinations and psychiatric symptoms, which treatment is indicated?",
    "options": {
      "A": "Quetiapine",
      "B": "Rivastigmine",
      "C": "Clozapine",
      "D": "Donepezil"
    },
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q126",
    "question_text": "",
    "options": {
      "A": "APP",
      "B": "APOE4",
      "C": "Presenilin 1",
      "D": "Presenilin 2"
    },
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q101",
    "question_text": "",
    "options": {
      "A": "Euphoria",
      "B": "Psychosis",
      "C": "Hyperactivity",
      "D": "Mania"
    },
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q20",
    "question_text": "",
    "options": {
      "A": "patient presents with young-onset familial Alzheimer's disease and a family history of the condition. What is the gene associated with this type of Alzheimer's?"
    },
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q127",
    "question_text": "Which of the following conditions is characterized by 3-repeat tau and ubiquitin?",
    "options": {
      "A": "FTD-pick",
      "B": "FTD-parkinsonism",
      "C": "bvFTD",
      "D": "FTD-ALS"
    },
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q80",
    "question_text": "Which of the following genes is commonly linked to Alzheimer's disease?",
    "options": {
      "A": "APOE4",
      "B": "APP",
      "C": "PSEN1",
      "D": "MAPT"
    },
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "subspecialty": "Dementia",
    "explanation": ""
  },
  {
    "question_number": "Q92",
    "question_text": "Which of the following genes is associated with familial Alzheimer\u2019s disease?",
    "options": {
      "A": "APP",
      "B": "PSEN1",
      "C": "PSEN2",
      "D": "Apolipoprotein E"
    },
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "subspecialty": "Dementia",
    "explanation": ""
  }
]